Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIO
2076
DELISTED
City Office REIT
CIO
| $1.76M | ﹤0.01% |
145,019
+75,177
| +108% | +$947K |
|
|
APFH
2077
DELISTED
AdvancePierre Foods Holdings
APFH
| $1.76M | ﹤0.01% |
+56,532
| New | +$1.63M |
|
2078
Tenet Healthcare
THC
$22.1B
| $1.76M | ﹤0.01% |
99,264
-73,004
| -42% | -$1.35M |
|
|
KND
2079
DELISTED
Kindred Healthcare
KND
| $1.76M | ﹤0.01% |
+210,498
| New | +$1.65M |
|
2080
CALL
Steel Dynamics
STLD
$33.8B
| $1.74M | ﹤0.01% |
+50,000
| New | +$1.78M |
|
|
SCNB
2081
DELISTED
Suffolk Bancorp
SCNB
| $1.73M | ﹤0.01% |
+42,779
| New | +$1.79M |
|
|
OMN
2082
DELISTED
OMNOVA Solutions Inc.
OMN
| $1.72M | ﹤0.01% |
174,147
+85,498
| +96% | +$788K |
|
2083
CALL
Mohawk Industries
MHK
$8.95B
| $1.72M | ﹤0.01% |
+7,500
| New | +$1.65M |
|
|
EPAY
2084
DELISTED
Bottomline Technologies Inc
EPAY
| $1.72M | ﹤0.01% |
+72,705
| New | +$1.83M |
|
|
XENT
2085
CALL
DELISTED
Intersect ENT, Inc
XENT
| $1.72M | ﹤0.01% |
+100,000
| New | +$1.4M |
|
|
GBNK
2086
DELISTED
Guaranty Bancorp
GBNK
| $1.72M | ﹤0.01% |
70,428
+2,520
| +4% | +$61.1K |
|
2087
PennantPark Floating Rate Capital
PFLT
$731M
| $1.71M | ﹤0.01% |
122,386
+80,093
| +189% | +$1.11M |
|
2088
EXL Service
EXLS
$5.69B
| $1.7M | ﹤0.01% |
+179,805
| New | +$1.69M |
|
2089
Abeona Therapeutics
ABEO
$344M
| $1.7M | ﹤0.01% |
13,600
-3,264
| -19% | -$421K |
|
|
NCV
2090
Virtus Convertible & Income Fund
NCV
$375M
| $1.7M | ﹤0.01% |
62,762
+51,211
| +443% | +$1.37M |
|
2091
Westwood Holdings Group
WHG
$189M
| $1.7M | ﹤0.01% |
31,762
+28,019
| +749% | +$1.6M |
|
2092
Beazer Homes USA
BZH
$884M
| $1.69M | ﹤0.01% |
139,497
-17,955
| -11% | -$231K |
|
2093
OneMain Financial
OMF
$7.26B
| $1.69M | ﹤0.01% |
68,105
-172,678
| -72% | -$4.34M |
|
|
GBL
2094
DELISTED
GAMCO Investors, Inc.
GBL
| $1.69M | ﹤0.01% |
57,190
+23,121
| +68% | +$696K |
|
2095
CALL
Semtech
SMTC
$13.1B
| $1.69M | ﹤0.01% |
50,000
| – | – |
|
|
BERY
2096
DELISTED
Berry Global Group, Inc.
BERY
| $1.69M | ﹤0.01% |
37,826
-1,537,095
| -98% | -$70.7M |
|
2097
Federated Hermes
FHI
$4.86B
| $1.68M | ﹤0.01% |
63,931
-228,117
| -78% | -$6.11M |
|
2098
VanEck Intermediate Muni ETF
ITM
$2.12B
| $1.68M | ﹤0.01% |
+35,885
| New | +$1.68M |
|
2099
CALL
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.68M | ﹤0.01% |
+200,000
| New | +$1.39M |
|
|
CDTX
2100
DELISTED
Cidara Therapeutics
CDTX
| $1.68M | ﹤0.01% |
10,764
+7,475
| +227% | +$1.31M |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $3.43B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.